Peptic Ulcer Drugs Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Peptic Ulcer 
Drugs Market Research 
and Forecast Report 
2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t he  l a t es t  r e po r t  by  I M ARC  G r oup ,  t i t l e d  " Pept i c  U l cer  Dru gs  M ark e t :  
G l o ba l  I ndu st ry  T re nds ,  Sh are ,  S i ze ,  G row t h ,  O pp or t u n i t y  an d  Fo recas t  20 24 -
2032 , "  t he  g loba l  pep t i c  u l ce r  d r ugs  m ar ke t  s i ze  r each ed  US $  4 . 8  B i l l i o n  i n  2023 .
A  pep t i c  u l ce r  i s  an  o pen  so r e  t ha t  deve lops  i n  t he  l i n i ng  o f  t h e  s t om ac h  t ha t  i s  
Report cau sed  du e  t o  i n f l am m at i on ,  r a d ia t i on  t he r a py ,  f r eque n t  o r a l  an d  i n jec t ab le  adm in i s t r a t i on  o f  as p i r i n s ,  and  a n t i - i n f l am m at o r y  d r u gs .  I t  i s  a sso c ia t ed  w i t h  
abdo m ina l  pa in ,  d i sc om f o r t ,  nause a ,  v om i t i ng ,  w e igh t  l oss ,  b loa t i ng ,  be l ch ing ,  and  
Highlight and l o ss  o f  a ppe t i t e .  
I t  i s  d iag nosed  t h r oug h  a  co m b ina t i on  o f  m e d ica l  h i s t o r y ,  phys i ca l  e xam ina t i o n ,  a nd  
d iagn os t i c  t es t s ,  such  a s  end oscop y ,  b loo d  and  s t oo l  t e s t s ,  and  b iops y .  I t  i s  t r e a t ed  
Description us ing  m e d ica t i ons  and  d r ug s ,  such  as  an t i b io t i c s ,  p r o t on  p um p  inh ib i t o r s  ( PP I ) ,  H2  
an t a gon is t s ,  an t a c ids ,  po t ass iu m - co m pe t i t i ve  ac i d  b lo cke r s  ( P - CAB ) ,  an d  u l ce r  
p r o t ec t i ve s ,  wh ich  a id  i n  r ed uc ing  t he  bo dy  a ches ,  m in im i z ing  a c id  s ec r e t i on ,  a nd  
p r o t ec t i ng  t he  s t o m ac h  f r o m  d ig es t i ve  j u i ce s .
Reque st  f o r  a  P DF  s ampl e  o f  t h i s  repor t :  
h t t p s : / / www. im ar c g r ou p . com / pep t i c - u l ce r - d r ugs - m ar ke t / r eque s t sam p le
Report Description
G l ob a l  Pe pt i c  U l c er  D rugs  M ark e t  T rend s :
The  su r g ing  p r ev a lenc e  o f  p ep t i c  u l ce r s  and  t h e  g r ow in g  g e r i a t r i c  popu la t i on  t ha t  i s  s usce p t i b le  t o  deve lo p ing  t hes e  
m ed ic a l  d i so r de r s  r e p r es en t  on e  o f  t he  m a jo r  f ac t o r s  d r i v i ng  t h e  dem and  f o r  p ep t i c  u l ce r  d r ugs  and  t r ea t m en t  a r ound  t h e  
wo r ld .  M or e ove r ,  t he  r i s in g  num ber  o f  i n d i v idua l s  su f f e r i ng  f r om  ob es i t y ,  unhea l t hy  l i f es t y le  hab i t s ,  and  i nc r eas in g  
i ns t an ces  o f  s t om a ch  c ance r  a r e  som e  o f  t he  o t he r  f ac t o r s  f avo r i ng  t he  g r ow t h  o f  t he  m a r ke t .  I n  ad d i t i on ,  gove r nm e n t s  o f  
num er ous  coun t r i es  a r e  i n i t i a t i ng  c am p a igns  t o  s p r ea d  awa r ene ss  ab ou t  t he  b ene f i t s  o f  ea r l y  d iag nos i s  o f  t he  d is eas e .  
Th i s ,  cou p led  w i t h  t he  expa nd ing  num ber  o f  c l i n i ca l  s t u d ies  and  t r i a l s  t o  de ve lop  new t r ea t m en t s  f o r  pep t i c  u l ce r s ,  i s  
con t r i bu t i n g  t o  t he  m ar ke t  g r ow t h .  Apa r t  f r o m  t h i s ,  t he  e asy  a va i l ab i l i t y  o f  v a r i ou s  gene r i c  d r u gs  f o r  t r ea t i ng  an d  
p r ev en t i ng  s t o m ach  and  i n t es t i na l  u l ce r s  and  gas t r oeso phag ea l  r e f l ux  d i se ase  ( G ERD )  v ia  o f f l i ne  an d  on l i n e  r e t a i l  
chann e ls  i s  s t r e ng t h en ing  t he  g r ow t h  o f  t he  m ar ke t .  Bes ide s  t h i s ,  s i gn i f i can t  im p r ove m en t s  i n  t h e  hea l t hca r e  
i n f r a s t r uc t u r e  and  d iagn os t i c  t ec hn o log ie s  a r e  c r ea t i n g  a  po s i t i ve  ou t l ook  f o r  t he  m ar ke t .
Look i ng  f o rw ard ,  t h e  m arke t  i s  an t i c i p a t e d  t o  rea ch  a  v a l ue  o f  US$  6 . 1  B i l l i on  b y  2 032 ,  exh i b i t i ng  a  C AG R o f  2 . 65%  
dur i ng  20 24 - 2 032 .
V i ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / pe pt i c - u l ce r - d ru gs- m ark e t
Product Type Insights:
• Proton Pump Inhibitors
• Potassium-Competit ive Acid Blocker (P-CAB)
• Antacids
• H2-Antagonists
• Antibiot ics
• Ulcer protective
Report 
Segmentation Ulcer Type Insights:
• Gastr ic Ulcer
• Duodenal Ulcer
• Others
Distribution Channel Insights:
• Hospita l  Pharmacies
• Retai l  Pharmacies
• Online Pharmacies
Regional Insights:
• North America
• Asia-Pacifi c
Report 
• Europe
Segmentation • Latin America
• Middle East and Afr ica
• Abbott Laboratories
• AstraZeneca plc
• Boehringer Ingelheim International  GmbH
Competitive 
• Novit ium Pharma LLC
Landscape • Pfi zer Inc.
with Key • PharmaKing Co. Ltd.
• RedHi l l  Biopharma Ltd
Players
• Viatr is  Inc.
• Yuhan Corporation
• Zydus Lifesciences Limited
How has the global peptic ulcer drugs market 
performed so far and how will it perform in the coming 
years?
What are the drivers, restraints, and opportunities in 
the global peptic ulcer drugs market?
What are the key regional markets?
Key 
Which countries represent the most attractive peptic 
ulcer drug markets?
Questions 
What is the breakup of the market based on the product 
Answered in type?
the Report What is the breakup of the market based on the ulcer 
type?
What is the breakup of the market based on the 
distribution channel?
What is the competitive structure of the global peptic 
ulcer drugs market?
Who are the key players/companies in the global peptic 
ulcer drugs market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  P e p t i c  U l c e r  D r u g s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t  T y p e
    6 . 1     P r o t o n  P u m p  I n h i b i t o r s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     P o t a s s i u m - C o m p e t i t i v e  A c i d  B l o c k e r  ( P - C A B )
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     A n t a c i d s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     H 2 - A n t a g o n i s t s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     A n t i b i o t i c s
        6 . 5 . 1  M a r k e t  T r e n d s
        6 . 5 . 2  M a r k e t  F o r e c a s t
    6 . 6     U l c e r  P r o t e c t i v e
        6 . 6 . 1  M a r k e t  T r e n d s
        6 . 6 . 2  M a r k e t  F o r e c a s t
7     M a r k e t  B r e a k u p  b y  U l c e r  T y p e
    7 . 1     G a s t r i c  U l c e r
Table of         7 . 1 . 1  M a r k e t  T r e n d s        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     D u o d e n a l  U l c e r
        7 . 2 . 1  M a r k e t  T r e n d s
Contents         7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     O t h e r s
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
8     M a r k e t  B r e a k u p  b y  D i s t r i b u t i o n  C h a n n e l
    8 . 1     H o s p i t a l  P h a r m a c i e s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     R e t a i l  P h a r m a c i e s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     O n l i n e  P h a r m a c i e s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /p ept i c -u l c e r-d rug s -m a rke t / t oc
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]